Telomir Pharmaceuticals (TELO), a pioneer in age-reversal science, has unveiled promising preclinical results highlighting the transformative potential of Telomir-1 in addressing Type 2 diabetes. Conducted in collaboration with India-based Pentagrit, the study evaluated Telomir-1 in zebrafish models of diabetes induced by high-calorie diets, revealing groundbreaking outcomes. Key findings include significant reductions in fasting glucose levels […]